Metagenomics Market Anticipated to Grow at an Impressive Rate during the Period


Posted March 11, 2019 by sunny88

The Metagenomics Market is expected to reach $ 523 million by 2024 with an annual growth rate of 16.8% over the forecast period.
 
Bioinformatics sector accounted for 1/5 of the total market share in 2017.
Metagenomics is a relatively new field that involves the collective genomic analysis of microbial population members as well as studying microbial interactions. In addition, metagenomic technology allows the study of whole organisms without the need to cultivate microbial communities. Because nonc cultivability and genomic diversity are two major obstacles to advances in environmental and clinical microbiology, metagenomics has gained tremendous traction among medical professionals and researchers.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/3724

In addition, technological advances in DNA sequencing are expected to increase demand for metanomic research worldwide. The same development focuses on the development of a DNA sequencing platform. Moreover, significant expansion of metadata applications over the years has complemented market growth. The Consumer segment generated the highest revenue in 2017 and is expected to retain its dominance throughout the forecast period. This is due to the high adoption rate of consumables in pre-sequencing, which is one of the most important steps in the entire sequencing protocol. These steps include sample preparation, sample processing, and metagenomic sequencing.

The Asia-Pacific region is expected to witness the highest growth rate throughout the forecast period, owing to its high population base, surge in disposable income, and rise in awareness towards new sequencing technologies. In addition, potential collaborations between the developed and developing economies working in the field of microbiome and metagenomics are the key contributors for the market growth in this region.

The major companies profiled in this report include
• Agilent Technologies Inc.
• Enterome SA
• F. Hoffmann-La Roche Ltd.
• Illumina Inc.
• Oxford Nanopore Technologies Ltd.
• Pacific Biosciences of California Inc.
• PerkinElmer Inc.
• Qiagen N.V.
• Swift Biosciences Inc.
• Thermo Fisher Scientific Inc.
The other players operating in the global metagenomics market include Siemens AG, ZS Genetics, Inc., Abbott Laboratories, Beckman Coulter, LI-COR, Genomatix GmbH, Beijing Genomics Institute, and Pieriandx.

Gauge & Software segments are expected to register the highest growth rate during the forecast period. A variety of tools and software are used throughout meta-analysis, sequencing, sequence binning, annotation, taxonomy classification, statistical analysis, data storage and sharing.

Make an Enquiry before Buy @ https://www.alliedmarketresearch.com/purchase-enquiry/3724


Key Findings of the Metagenomics Market:
• The sequencing segment accounted for four-fifths of the total market share in 2017.
• The environmental remediation segment registered the second-highest growth rate among applications with a CAGR of 17.4% from 2018 to 2024.
• North America dominated the global metagenomics market, accounting for the maximum share in 2017, and is expected to retain the same trend during the forecast period.
• India has registered the highest growth rate in the Asia-Pacific metagenomics market with a CAGR of 19.7% during the forecast period.
• Germany accounted for two-sevenths of the total share in the European metagenomics market in 2017.

Access Full Summery @ https://www.alliedmarketresearch.com/metagenomics-market
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By ALLIED MARKET RESEARCH
Business Address 5933 NE Win Sivers Drive, #205, Portland, OR 97220, United States. Int'l: +1-503-894-6022 Toll Free: +1-800-792-5285 Fax: +1-800-792-5285 [email protected]
Country United States
Categories Industry , Medical , Research
Last Updated March 11, 2019